Top

Published in:

Open Access 01-12-2022 | Long-COVID Syndrome | Guidelines

Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German society of neurology

Authors: Christiana Franke, Peter Berlit, Harald Prüss

Published in: Neurological Research and Practice | Issue 1/2022

Abstract

Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to COVID-19 (COrona VIrus Disease-2019). SARS-CoV-2 acute infection may be associated with an increased incidence of neurological manifestations such as encephalopathy and encephalomyelitis, ischemic stroke and intracerebral hemorrhage, anosmia and neuromuscular diseases. Neurological manifestations are commonly reported during the post-acute phase and are also present in Long-COVID (LCS) and post-COVID-19 syndrome (PCS). In October 2020, the German Society of Neurology (DGN, Deutsche Gesellschaft für Neurologie) published the first guideline on the neurological manifestations of COVID-19. In December 2021 this S1 guideline was revised and guidance for the care of patients with post-COVID-19 syndrome regarding neurological manifestations was added. This is an abbreviated version of the post-COVID-19 syndrome chapter of the guideline issued by the German Neurological society and published in the Guideline repository of the AWMF (Working Group of Scientific Medical Societies; Arbeitsgemeinschaft wissenschaftlicher Medizinischer Fachgesellschaften).

Alemanno, F., Houdayer, E., Parma, A., Spina, A., Del Forno, A., Scatolini, A., & Iannaccone, S. (2021). COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience. PLoS ONE, 16(2), e0246590. https://doi.org/10.1371/journal.pone.0246590CrossRefPubMedPubMedCentral

Augustin, M., Schommers, P., Stecher, M., Dewald, F., Gieselmann, L., Gruell, H., & Lehmann, C. (2021). Post-COVID syndrome in non-hospitalised patients with COVID-19: A longitudinal prospective cohort study. The Lancet Regional Health-Europe, 6, 100122. https://doi.org/10.1016/j.lanepe.2021.100122CrossRefPubMedPubMedCentral

Baghbanian, S. M., & Namazi, F. (2021). Post COVID-19 longitudinally extensive transverse myelitis (LETM)-a case report. Acta Neurologica Belgica, 121(6), 1875–1876. https://doi.org/10.1007/s13760-020-01497-xCrossRefPubMed

Becker, J. H., Lin, J. J., Doernberg, M., Stone, K., Navis, A., Festa, J. R., & Wisnivesky, J. P. (2021). Assessment of cognitive function in patients after COVID-19 infection. JAMA Network Open, 4(10), e2130645. https://doi.org/10.1001/jamanetworkopen.2021.30645CrossRefPubMedPubMedCentral

Blazhenets, G., Schroeter, N., Bormann, T., Thurow, J., Wagner, D., Frings, L., & Hosp, J. A. (2021). Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. Journal of Nuclear Medicine, 62(7), 910–915. https://doi.org/10.2967/jnumed.121.262128CrossRefPubMedPubMedCentral

Boesl, F., Audebert, H., Endres, M., Pruss, H., & Franke, C. (2021). A neurological outpatient clinic for patients with post-COVID-19 syndrome—A report on the clinical presentations of the first 100 patients. Frontiers in Neurology, 12, 738405. https://doi.org/10.3389/fneur.2021.738405CrossRefPubMedPubMedCentral

Bozzali, M., Grassini, A., Morana, G., Zotta, M., Cabras, S., Romagnolo, A., & Lopiano, L. (2021). Focal seizures with impaired awareness as long-term neurological complication of COVID-19: A case report. Neurological Sciences, 42(7), 2619–2623. https://doi.org/10.1007/s10072-021-05233-yCrossRefPubMedPubMedCentral

Carfi, A., Bernabei, R., Landi, F., & GemelliAgainst, C.-P.-A.C.S.G. (2020). Persistent symptoms in patients after acute COVID-19. JAMA, 324(6), 603–605. https://doi.org/10.1001/jama.2020.12603CrossRefPubMedPubMedCentral

Carroll, E., Neumann, H., Aguero-Rosenfeld, M. E., Lighter, J., Czeisler, B. M., Melmed, K., & Lewis, A. (2020). Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus. Epilepsia, 61(10), e135–e139. https://doi.org/10.1111/epi.16683CrossRefPubMed

10.

Ceban, F., Ling, S., Lui, L. M. W., Lee, Y., Gill, H., Teopiz, K. M., & McIntyre, R. S. (2022). Fatigue and cognitive impairment in post-COVID-19 syndrome: A systematic review and meta-analysis. Brain, Behavior, and Immunity, 101, 93–135. https://doi.org/10.1016/j.bbi.2021.12.020CrossRefPubMed

11.

Chen, C., Haupert, S. R., Zimmermann, L., Shi, X., Fritsche, L. G., & Mukherjee, B. (2022). Global prevalence of post COVID-19 condition or long COVID: A meta-analysis and systematic review. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiac136CrossRefPubMed

12.

Damm, M., Schmitl, L., Muller, C. A., Welge-Lussen, A., & Hummel, T. (2019). Diagnostics and treatment of olfactory dysfunction. HNO, 67(4), 274–281. https://doi.org/10.1007/s00106-019-0614-xCrossRefPubMed

13.

Douaud, G., Lee, S., Alfaro-Almagro, F., Arthofer, C., Wang, C., McCarthy, P., & Smith, S. M. (2022). SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature, 604(7907), 697–707. https://doi.org/10.1038/s41586-022-04569-5CrossRefPubMedPubMedCentral

14.

Fernandez-de-Las-Penas, C., Gomez-Mayordomo, V., Cuadrado, M. L., Palacios-Cena, D., Florencio, L. L., Guerrero, A. L., & Arendt-Nielsen, L. (2021). The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study. Cephalalgia, 41(13), 1332–1341. https://doi.org/10.1177/03331024211020404CrossRefPubMedPubMedCentral

15.

Havers, F. P., Reed, C., Lim, T., Montgomery, J. M., Klena, J. D., Hall, A. J., & Thornburg, N. J. (2020). Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-May 12, 2020. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2020.4130CrossRefPubMedPubMedCentral

16.

Hosp, J. A., Dressing, A., Blazhenets, G., Bormann, T., Rau, A., Schwabenland, M., & Meyer, P. T. (2021). Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain, 144(4), 1263–1276. https://doi.org/10.1093/brain/awab009CrossRefPubMed

17.

Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., & Cao, B. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet, 397(10270), 220–232. https://doi.org/10.1016/S0140-6736(20)32656-8CrossRefPubMedPubMedCentral

18.

Huart, C., Philpott, C. M., Altundag, A., Fjaeldstad, A. W., Frasnelli, J., Gane, S., & Hummel, T. (2021). Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: An international view. International Forum of Allergy & Rhinology, 11(7), 1041–1046. https://doi.org/10.1002/alr.22788CrossRef

19.

Kanberg, N., Ashton, N. J., Andersson, L. M., Yilmaz, A., Lindh, M., Nilsson, S., & Gisslen, M. (2020). Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology, 95(12), e1754–e1759. https://doi.org/10.1212/WNL.0000000000010111CrossRefPubMed

20.

Kandemirli, S. G., Altundag, A., Yildirim, D., TekcanSanli, D. E., & Saatci, O. (2021). Olfactory bulb MRI and paranasal sinus CT findings in persistent COVID-19 anosmia. Academic Radiology, 28(1), 28–35. https://doi.org/10.1016/j.acra.2020.10.006CrossRefPubMed

21.

Kedor, C. (2021). Chronic COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) following the first pandemic wave in Germany: A first analysis of a prospective observational study. MedRxiv. https://doi.org/10.1101/2021.02.06.21249256CrossRef

22.

Kim, J. W., Abdullayev, N., Neuneier, J., Fink, G. R., & Lehmann, H. C. (2021). Post-COVID-19 encephalomyelitis. Neurological Research Practice, 3(1), 18. https://doi.org/10.1186/s42466-021-00113-4CrossRefPubMedPubMedCentral

23.

Larsen, N. W., Stiles, L. E., & Miglis, M. G. (2021). Preparing for the long-haul: Autonomic complications of COVID-19. Autonomic Neuroscience, 235, 102841. https://doi.org/10.1016/j.autneu.2021.102841CrossRefPubMedPubMedCentral

24.

Lopez-Leon, S., Wegman-Ostrosky, T., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., & Villapol, S. (2021). More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Science and Reports, 11(1), 16144. https://doi.org/10.1038/s41598-021-95565-8CrossRef

25.

Matta, J., Wiernik, E., Robineau, O., Carrat, F., Touvier, M., Severi, G., Sante, P. R. e. I. S. e. P. G. P. l. C. C.-S. S. G. (2022). Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among french adults during the COVID-19 pandemic. JAMA Intern Med, 182(1), 19–25. https://doi.org/10.1001/jamainternmed.2021.6454

26.

Nersesjan, V., Fonsmark, L., Christensen, R. H. B., Amiri, M., Merie, C., Lebech, A. M., & Benros, M. E. (2022). Neuropsychiatric and cognitive outcomes in patients 6 months after COVID-19 requiring hospitalization compared with matched control patients hospitalized for non-COVID-19 illness. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2022.0284CrossRefPubMed

27.

Pistarini, C., Fiabane, E., Houdayer, E., Vassallo, C., Manera, M. R., & Alemanno, F. (2021). Cognitive and emotional disturbances due to COVID-19: An exploratory study in the rehabilitation setting. Frontiers in Neurology, 12, 643646. https://doi.org/10.3389/fneur.2021.643646CrossRefPubMedPubMedCentral

28.

Premraj, L., Kannapadi, N. V., Briggs, J., Seal, S. M., Battaglini, D., Fanning, J., & Cho, S. M. (2022). Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. Journal of the Neurological Sciences, 434, 120162. https://doi.org/10.1016/j.jns.2022.120162CrossRefPubMedPubMedCentral

29.

Rajan, S., Khunti, K., Alwan, N., Steves, C., MacDermott, N., Morsella, A., & McKee, M. (2021). In the wake of the pandemic: Preparing for Long COVID. Copenhagen (Denmark).

30.

Rass, V., Beer, R., Schiefecker, A. J., Kofler, M., Lindner, A., Mahlknecht, P., & Helbok, R. (2021). Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. European Journal of Neurology, 28(10), 3348–3359. https://doi.org/10.1111/ene.14803CrossRefPubMed

31.

Rudroff, T., Fietsam, A. C., Deters, J. R., Bryant, A. D., & Kamholz, J. (2020). Post-COVID-19 fatigue: Potential contributing factors. Brain Science. https://doi.org/10.3390/brainsci10121012CrossRef

32.

Schweitzer, F., Goereci, Y., Franke, C., Silling, S., Bosl, F., Maier, F., & Warnke, C. (2022). Cerebrospinal fluid analysis post-COVID-19 is not suggestive of persistent central nervous system infection. Annals of Neurology, 91(1), 150–157. https://doi.org/10.1002/ana.26262CrossRefPubMed

33.

Seessle, J., Waterboer, T., Hippchen, T., Simon, J., Kirchner, M., Lim, A., & Merle, U. (2021). Persistent symptoms in adult patients one year after COVID-19: A prospective cohort study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciab611CrossRefPubMed

34.

Townsend, L., Dyer, A. H., Jones, K., Dunne, J., Mooney, A., Gaffney, F., & Conlon, N. (2020). Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE, 15(11), e0240784. https://doi.org/10.1371/journal.pone.0240784CrossRefPubMedPubMedCentral

35.

Writing Committee for the, C. S. G., Morin, L., Savale, L., Pham, T., Colle, R., Figueiredo, S., & Monnet, X. (2021). Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA, 325(15), 1525–1534. https://doi.org/10.1001/jama.2021.3331

36.

Wu, S. L., Mertens, A. N., Crider, Y. S., Nguyen, A., Pokpongkiat, N. N., Djajadi, S., & Benjamin-Chung, J. (2020). Substantial underestimation of SARS-CoV-2 infection in the United States. Nature Communications, 11(1), 4507. https://doi.org/10.1038/s41467-020-18272-4CrossRefPubMedPubMedCentral

37.

Xie, Y., Xu, E., Bowe, B., & Al-Aly, Z. (2022). Long-term cardiovascular outcomes of COVID-19. Nature Medicine, 28(3), 583–590. https://doi.org/10.1038/s41591-022-01689-3CrossRefPubMedPubMedCentral

38.

Zoghi, A., Ramezani, M., Roozbeh, M., Darazam, I. A., & Sahraian, M. A. (2020). A case of possible atypical demyelinating event of the central nervous system following COVID-19. Multiple Sclerosis and Related Disorders, 44, 102324. https://doi.org/10.1016/j.msard.2020.102324CrossRefPubMedPubMedCentral

Title: Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German society of neurology
Authors: Christiana Franke
Peter Berlit
Harald Prüss
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Long-COVID Syndrome
Myalgie
Myalgia
SARS-CoV-2
COVID-19
Headache
Fatigue
Anosmia
Published in: Neurological Research and Practice / Issue 1/2022
Electronic ISSN: 2524-3489
DOI: https://doi.org/10.1186/s42466-022-00191-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German society of neurology

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2022

COVID-19 outcomes in hospitalized Parkinson’s disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline

Recovery of intracranial stenoses in varicella zoster virus vasculitis after long-term treatment with valacyclovir and prednisolone

Brain tumor related epilepsy: pathophysiological approaches and rational management of antiseizure medication

No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache

LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination